Children's Oncology Group
Clinical trials sponsored by Children's Oncology Group, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Smart treatment strategy aims to spare kids with neuroblastoma from unnecessary side effects Results expected Sep 2026 (estimated)
- Can genes explain why some kids with birth defects develop cancer? Results expected Sep 2026 (estimated)
- Liver shield: nutrient may prevent chemo side effect in young leukemia patients Results expected Sep 2026 (estimated)
- New dosing method for Kids' cancer drug aims to reduce side effects Results expected Sep 2026 (estimated)
- Could a Baby's cord blood predict leukemia years later? Results expected Sep 2026 (estimated)
-
A pill that blocks RAS: can it help children whose tumors came back?
Disease control Not yet recruitingResearchers are testing daraxonrasib, an experimental pill that blocks RAS proteins, in children with solid tumors that have come back or stopped responding to treatment. The tumors include neuroblastoma and rhabdomyosarcoma, and all carry RAS mutations. The trial has two parts: …
Phase 1/2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could an antibody boost chemo for tough blood cancers?
Disease control Not yet recruitingThis large clinical trial is testing whether adding the drug daratumumab to standard chemotherapy helps children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL). Daratumumab is an antibody that targets a pr…
Phase 2/3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC